2014-2018年美国需要延长急性机械通气与短期机械通气患者的特征、住院过程与结局
该回顾性队列利用Premier数据库2014-2018年美国787家急性收治医院数据,纳入691,961例机械通气患者,其中266,374例(38.5%)接受延长急性机械通气(≥4天)。延长急性机械通气组基线合并症负担更高(Charlson评分3.5±2.7 vs 3.1±2.7),血管加压药使用(50.3% vs 36.9%)、透析(19.4% vs 10.3%)、严重脓毒症(20.3% vs 10.3%)和脓毒性休克(33.5% vs 15.9%)比例均更高。延长急性机械通气组住院死亡率(29.75% vs 21.1%)、合并死亡或出院转临终关怀(37.2% vs 25.3%)、拔管失败(12.3% vs 6.1%)、气管切开(21.6% vs 4.5%)、艰难梭菌感染(4.5% vs 1.7%)及呼吸机相关性肺炎发生密度(2.4/1000患者日 vs 0.6/1000患者日)均更高,机械通气开始后住院时间中位数13天(IQR 8-20)vs 4天(IQR 1-8),住院费用中位数55,014美元(IQR 35,051-88,007)vs 20,120美元(IQR 12,071-34,915)。
要点
- 在美国787家急性收治医院2014-2018年691,961例机械通气患者中,38.5%(266,374例)需要延长急性机械通气(≥4天)。
- 延长急性机械通气组住院死亡率29.75%,高于短期机械通气组的21.1%;合并死亡或出院转临终关怀37.2% vs 25.3%。
- 延长急性机械通气组拔管失败12.3% vs 6.1%,气管切开21.6% vs 4.5%,艰难梭菌感染4.5% vs 1.7%。
- 延长急性机械通气组呼吸机相关性肺炎发生密度2.4/1000患者日,高于短期机械通气组的0.6/1000患者日。
- 延长急性机械通气组机械通气开始后住院时间中位数13天(IQR 8-20)vs 4天(IQR 1-8),住院费用中位数55,014美元(IQR 35,051-88,007)vs 20,120美元(IQR 12,071-34,915)。
适用人群与场景
- 美国787家急性收治医院2014-2018年收治的机械通气患者,数据来源于Premier数据库。
- 延长急性机械通气定义为机械通气≥4天;短期机械通气定义为机械通气<4天。
诊断标准与关键阈值
- 延长急性机械通气:机械通气≥4天;短期机械通气:机械通气<4天。
研究设计与关键结果
- 研究类型为回顾性队列,纳入691,961例机械通气患者,其中266,374例(38.5%)接受延长急性机械通气。
- 延长急性机械通气组与短期机械通气组基线年龄(62.0±15.8岁 vs 61.7±17.2岁)、男性比例(55.6% vs 53.9%)、白人比例(69.1% vs 72.4%)相似,但延长急性机械通气组Charlson合并症评分更高(3.5±2.7 vs 3.1±2.7)。
- 延长急性机械通气组血管加压药使用50.3% vs 36.9%,透析19.4% vs 10.3%,严重脓毒症20.3% vs 10.3%,脓毒性休克33.5% vs 15.9%,均高于短期机械通气组。
- 延长急性机械通气组住院死亡率29.75% vs 21.1%,合并死亡或出院转临终关怀37.2% vs 25.3%,拔管失败12.3% vs 6.1%,气管切开21.6% vs 4.5%,艰难梭菌感染4.5% vs 1.7%,呼吸机相关性肺炎发生密度2.4/1000患者日 vs 0.6/1000患者日,均高于短期机械通气组。
- 延长急性机械通气组机械通气开始后住院时间中位数13天(IQR 8-20)vs 4天(IQR 1-8),住院费用中位数55,014美元(IQR 35,051-88,007)vs 20,120美元(IQR 12,071-34,915),均高于短期机械通气组。
证据类型、等级与局限
- 证据类型:回顾性队列研究,基于行政编码识别延长急性机械通气与短期机械通气患者。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,超过三分之一的住院机械通气患者需要机械通气≥4天;延长急性机械通气患者慢性与急性疾病负担均更高,且住院获得性并发症发生率及临床与经济结局均差于短期机械通气患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Most patients requiring mechanical ventilation only require it for a short term (< 4 d of mechanical ventilation). Those undergoing prolonged acute mechanical ventilation (≥ 4 d mechanical ventilation) represent a select cohort who face significant morbidity, mortality, and resource utilization. Using administrative codes, we identified prolonged acute mechanical ventilation and short-term mechanical ventilation patients and compared their baseline characteristics, hospital events, and hospital outcomes.
DESIGN: Retrospective cohort.
SETTING: Seven-hundred eighty-seven acute care hospitals, United States, contributing data to Premier database, 2014-2018.
PATIENTS: Patients on mechanical ventilation.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Among 691,961 patients meeting the enrollment criteria, 266,374 (38.5%) received prolonged acute mechanical ventilation. At baseline, patients on prolonged acute mechanical ventilation were similar to short-term mechanical ventilation in age (years: 62.0 ± 15.8 prolonged acute mechanical ventilation vs 61.7 ± 17.2 short-term mechanical ventilation), gender (males: 55.6% prolonged acute mechanical ventilation vs 53.9% short-term mechanical ventilation), and race (white: 69.1% prolonged acute mechanical ventilation vs 72.4% short-term mechanical ventilation). The prolonged acute mechanical ventilation group had a higher comorbidity burden than short-term mechanical ventilation (mean Charlson Score 3.5 ± 2.7 vs 3.1 ± 2.7). The prevalence of vasopressors (50.3% vs 36.9%), dialysis (19.4% vs 10.3%), severe sepsis (20.3% vs 10.3%), and septic shock (33.5% vs 15.9%) was higher in prolonged acute mechanical ventilation than short-term mechanical ventilation. Hospital mortality (29.75% vs 21.1%), combined mortality, or discharge to hospice (37.2% vs 25.3%), extubation failure (12.3% vs 6.1%), tracheostomy (21.6% vs 4.5%), development of Clostridium difficile (4.5% vs 1.7%), and incidence density of ventilator-associated pneumonia (2.4/1,000 patient-days vs 0.6/1,000 patient-days) were all higher in the setting of prolonged acute mechanical ventilation than short-term mechanical ventilation. Median (interquartile range) post mechanical ventilation onset length of stay (13 [8-20] vs 4 d [1-8 d]) and hospital costs ($55,014 [$35,051-$88,007] vs $20,120 [$12,071-$34,915] were higher in prolonged acute mechanical ventilation than short-term mechanical ventilation.
CONCLUSIONS: Over one-third of all hospitalized patients on mechanical ventilation require it for greater than or equal to 4 days. Prolonged acute mechanical ventilation patients exhibit a higher burden of both chronic and acute illness and experience higher rates than those on short-term mechanical ventilation of hospital-acquired complications and worse clinical and economic outcomes.
参考来源
- Zilberberg MD, Nathanson BH, Ways J, et al. Characteristics, Hospital Course, and Outcomes of Patients Requiring Prolonged Acute Versus Short-Term Mechanical Ventilation in the United States, 2014-2018. Crit Care Med. 2020. PMID: 33045151. doi:10.1097/CCM.0000000000004525
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。